• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    FIGS Announces Date of Fourth Quarter and Full Year 2024 Earnings Release, Conference Call and Webcast

    2/6/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary
    Get the next $FIGS alert in real time by email

    FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a fourth quarter and full year 2024 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx.

    FIGS Fourth Quarter and Full Year 2024 Earnings and Conference Call

    Date: Thursday, February 27, 2025

    Time: 2:00 p.m. PT / 5:00 p.m. ET

    Live Call: (833) 470-1428 (US) or +1 404 975 4839 (International)

    • Conference ID: 686323

    Replay: (866) 813-9403 (US) or +1 929 458 6194 (International)

    • Conference ID: 185176
    • The replay will be available from approximately two hours after the completion of the live call through March 6, 2025

    Webcast: https://ir.wearfigs.com/events-and-presentations/events/default.aspx

    Disclosure Information

    FIGS uses the ir.wearfigs.com website, as well as press releases, filings with the U.S. Securities and Exchange commission and public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public and for complying with our disclosure obligations under Regulation FD.

    About FIGS

    FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower and serve current and future generations of healthcare professionals. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function and style. We share stories about healthcare professionals' experiences in ways that inspire them. We build meaningful connections within the healthcare community that we created. Above all, we seek to make an impact for our community, including by advocating for them and always having their backs.

    We serve healthcare professionals in numerous countries in North America, Europe, the Asia Pacific region and the Middle East. We also serve healthcare institutions through our TEAMS platform.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250206009141/en/

    Investors:

    Tom Shaw

    [email protected]

    Media:

    Todd Maron

    [email protected]

    Get the next $FIGS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FIGS

    DatePrice TargetRatingAnalyst
    5/5/2025$7.00 → $5.00Market Perform
    Telsey Advisory Group
    8/9/2024$6.00 → $7.00Market Perform
    Telsey Advisory Group
    4/2/2024$8.50 → $4.50Neutral → Underperform
    BofA Securities
    3/8/2024Outperform → Perform
    Oppenheimer
    2/29/2024$6.00Outperform → Market Perform
    Telsey Advisory Group
    1/24/2024$7.00Underweight → Equal Weight
    Barclays
    7/17/2023Outperform → Mkt Perform
    Raymond James
    5/3/2023$9.00Buy
    ROTH MKM
    More analyst ratings